Stockreport

Y-mAbs Deepens Radiopharmaceutical Leadership with Appointment of Norman LaFrance, M.D. as Chief Development Officer [Yahoo! Finance]

PLUS THERAPEUTICS, Inc.  (PSTV) 
PDF company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the treatment of cancer, today announced [Read more]